Dasatinib inhibits CXCR4 signaling in chronic lymphocytic leukaemia cells and impairs migration towards CXCL12.
Chemokines and their ligands play a critical role in enabling chronic lymphocytic leukaemia (CLL) cells access to protective microenvironmental niches within tissues, ultimately resulting in chemoresistance and relapse: disruption of these signaling pathways has become a novel therapeutic approach i...
Saved in:
| Main Authors: | Alison M McCaig, Emilio Cosimo, Michael T Leach, Alison M Michie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0048929&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CXCR7 functions as a scavenger for CXCL12 and CXCL11.
by: Ulrike Naumann, et al.
Published: (2010-02-01) -
Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debate
by: Hussam A. S. Murad, et al.
Published: (2021-01-01) -
GPR15LG binds CXCR4 and synergistically modulates CXCL12-induced cell signaling and migration
by: Dan Pascal Jean Albers, et al.
Published: (2025-05-01) -
Nanoparticle‐Mediated CXCL12–CXCR4 Inhibition Reprograms Macrophages and Suppresses Gastric Carcinoma
by: Qianqian Cao, et al.
Published: (2025-08-01) -
The CXCL12/CXCR4 Axis: An Emerging Therapeutic Target for Chronic Pain
by: Chen Z, et al.
Published: (2025-05-01)